Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide for hospitalized children with acute gastroenteritis
ACTRN12614000381684Phase 4Terminated
- Sponsor
- Kids Research Institute Australia
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute gastroenteritis comparing Nitazoxanide with Placebo (2 arms). Primary endpoint: Average time period of significant illness. Started Nov 2014; status: terminated.
02
Drugs
nitazoxanide
03
Conditions
acute gastroenteritis
Beyond the preview
Go deeper on ACTRN12614000381684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000381684.